Crossmark Global Holdings’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.5M | Buy |
65,193
+2,087
| +3% | +$434K | 0.2% | 112 |
|
|
2026
Q1 | $13.3M | Buy |
63,106
+1,055
| +2% | +$227K | 0.2% | 121 |
|
|
2025
Q4 | $12.8M | Buy |
62,051
+2,095
| +3% | +$394K | 0.18% | 129 |
|
|
2025
Q3 | $9.41M | Buy |
59,956
+3,434
| +6% | +$530K | 0.14% | 171 |
|
|
2025
Q2 | $9.5M | Sell |
56,522
-2,943
| -5% | -$437K | 0.15% | 160 |
|
|
2025
Q1 | $8.19M | Sell |
59,465
-13,122
| -18% | -$1.67M | 0.14% | 173 |
|
|
2024
Q4 | $8.59M | Sell |
72,587
-1,405
| -2% | -$164K | 0.16% | 157 |
|
|
2024
Q3 | $8.18M | Sell |
73,992
-676
| -0.9% | -$70.7K | 0.15% | 172 |
|
|
2024
Q2 | $7.34M | Buy |
74,668
+8,786
| +13% | +$895K | 0.14% | 168 |
|
|
2024
Q1 | $7.37M | Sell |
65,882
-1,459
| -2% | -$157K | 0.14% | 171 |
|
|
2023
Q4 | $6.79M | Sell |
67,341
-136,886
| -67% | -$13.6M | 0.14% | 173 |
|
|
2023
Q3 | $18.7M | Buy |
204,227
+137,175
| +205% | +$12.4M | 0.42% | 45 |
|
|
2023
Q2 | $6.15M | Sell |
67,052
-4,726
| -7% | -$399K | 0.13% | 188 |
|
|
2023
Q1 | $5.42M | Sell |
71,778
-732
| -1% | -$55.2K | 0.13% | 196 |
|
|
2022
Q4 | $5.57M | Buy |
72,510
+7,208
| +11% | +$548K | 0.14% | 188 |
|
|
2022
Q3 | $4.35M | Sell |
65,302
-712
| -1% | -$45.1K | 0.12% | 201 |
|
|
2022
Q2 | $3.45M | Sell |
66,014
-184,970
| -74% | -$10.5M | 0.09% | 254 |
|
|
2022
Q1 | $14.2M | Buy |
250,984
+14,729
| +6% | +$789K | 0.32% | 71 |
|
|
2021
Q4 | $12.2M | Sell |
236,255
-6,000
| -2% | -$294K | 0.26% | 97 |
|
|
2021
Q3 | $12M | Buy |
242,255
+9,755
| +4% | +$529K | 0.28% | 92 |
|
|
2021
Q2 | $13.3M | Buy |
232,500
+202,821
| +683% | +$11.9M | 0.31% | 75 |
|
|
2021
Q1 | $1.8M | Sell |
29,679
-1,312
| -4% | -$72.4K | 0.04% | 401 |
|
|
2020
Q4 | $1.66M | Buy |
30,991
+6,102
| +25% | +$317K | 0.04% | 418 |
|
|
2020
Q3 | $1.17M | Sell |
24,889
-620
| -2% | -$31.8K | 0.03% | 490 |
|
|
2020
Q2 | $1.33M | Buy |
25,509
+1,779
| +7% | +$91.7K | 0.04% | 444 |
|
|
2020
Q1 | $1.14M | Buy |
23,730
+235
| +1% | +$12.2K | 0.04% | 428 |
|
|
2019
Q4 | $1.19M | Sell |
23,495
-19,870
| -46% | -$1.03M | 0.03% | 511 |
|
|
2019
Q3 | $2.05M | Sell |
43,365
-1,327
| -3% | -$60.6K | 0.06% | 349 |
|
|
2019
Q2 | $2.1M | Buy |
44,692
+1,519
| +4% | +$70.1K | 0.06% | 373 |
|
|
2019
Q1 | $2.08M | Buy |
43,173
+235
| +0.5% | +$11.8K | 0.06% | 365 |
|
|
2018
Q4 | $1.92M | Sell |
42,938
-1,373
| -3% | -$71.6K | 0.06% | 366 |
|
|
2018
Q3 | $2.39M | Buy |
44,311
+458
| +1% | +$23.4K | 0.06% | 358 |
|
|
2018
Q2 | $2.14M | Sell |
43,853
-1,190
| -3% | -$67.5K | 0.06% | 371 |
|
|
2018
Q1 | $2.82M | Sell |
45,043
-6,511
| -13% | -$447K | 0.07% | 322 |
|
|
2017
Q4 | $3.16M | Buy |
51,554
+6,696
| +15% | +$414K | 0.08% | 314 |
|
|
2017
Q3 | $3M | Buy |
+44,858
| New | +$3.17M | 0.08% | 308 |
|
|
2016
Q3 | $3M | Buy |
+44,858
| New | +$3.63M | 0.08% | 308 |
|
Other funds holding CAH
KC
ORIO
WCM
QCM
P
CAMG
YCM
KL
Crossmark Global Holdings's CAH Position: Q2 2026 in Review
Crossmark Global Holdings increased its Cardinal Health (CAH) stake by 3.3% in Q2 2026, buying an estimated $434K and bringing the position to 65,193 shares worth $15.5M. The position accounts for 0.2% of the portfolio, ranked #112.
Crossmark Global Holdings first reported a position in CAH in Q3 2016 and has held it in 37 quarters since. The position peaked at $18.7M in Q3 2023. 218 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Crossmark Global Holdings held 65,193 shares of Cardinal Health worth $15.5M as of Q2 2026.
- Crossmark Global Holdings bought 2,087 Cardinal Health shares in Q2 2026, an estimated $434K.
- Cardinal Health made up 0.2% of Crossmark Global Holdings's portfolio in Q2 2026, its #112 holding.
- Crossmark Global Holdings first reported a position in Cardinal Health in Q3 2016 and has held it in 37 quarters since.
- Crossmark Global Holdings's Cardinal Health position peaked at $18.7M in Q3 2023.
- 218 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.